Document is current
Any future updates will be listed below
-
Authors
Tseng, Tzu-Hao
Chen, Chao-Ping
Jiang, Ching-Chuan
Weng, Pei-Wei
Chan, Yi-Sheng
Hsu, Horng-Chaung
Chiang, Hongsen https://orcid.org/0000-0001-8781-5146
-
Funding
Funding for this research was provided by:
BioGend Therapeutics Co.Ltd.
- License Information
-
More Information
Article History
Received: 24 July 2024
Accepted: 2 November 2024
First Online: 30 November 2024
Declarations
:
: This multicenter, randomized controlled, non-inferiority trial was conducted across nine hospitals in Taiwan, following approval from the institutional review board/institutional ethical committee of each hospital and registration on the Clinical Trials Open Registry (, ID: NCT01477008). The protocol and subject-related documents underwent review and approval by the Taiwan Food and Drug Administration (TFDA).
: Not applicable.
: The authors declare that they have no competing interests.
